TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88712802

Filing Date: 12/03/2019

To the Commissioner for Trademarks:

MARK: FLORINEF (Standard Characters, see mark)
The literal element of the mark consists of FLORINEF. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, CASPER PHARMA LLC, a limited liability company legally organized under the laws of New Jersey, having an address of
      2 TOWER CENTER BOULEVARD, SUITE 1101C
      2 TOWER CENTER BOULEVARD, SUITE 1101C
      EAST BRUNSWICK, New Jersey 08816
      United States
      732-243-0042(phone)
      732-227-1513(fax)
      btustin@casperpharma.com

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Cortical steroid preparation
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

The applicant's current Correspondence Information:

CASPER PHARMA LLC

CASPER PHARMA LLC

2 TOWER CENTER BOULEVARD, SUITE 1101C       2 TOWER CENTER BOULEVARD, SUITE 1101C

EAST BRUNSWICK, New Jersey 08816

732-243-0042(phone)

732-227-1513(fax)

btustin@casperpharma.com; edwardn@cronuspharmausa.com (authorized). Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

The attorney docket/reference number is TMK-2019-02.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Edward Neugeboren/   Date: 12/03/2019
Signatory's Name: Edward Neugeboren
Signatory's Position: Chief Strategy Officer
Payment Sale Number: 88712802
Payment Accounting Date: 12/03/2019

Serial Number: 88712802
Internet Transmission Date: Tue Dec 03 11:08:06 EST 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2019120311080608
9618-88712802-70027d4db3cf65491e72e6a841
bc909bf473b7f990ccc91ab78fa93ee5111bdc51
-CC-08050606-20191125152916885118